BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 9649918)

  • 61. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
    Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative immunologic assay of human chorionic gonadotropin in normal and abnormal pregnancies.
    Mishell DR; Davajan V
    Am J Obstet Gynecol; 1966 Sep; 96(2):231-9. PubMed ID: 5921063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A; Kainz C
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
    Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phantom hCG and phantom choriocarcinoma.
    Cole LA
    Gynecol Oncol; 1998 Nov; 71(2):325-9. PubMed ID: 9826481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cervical choriocarcinoma associated with an intrauterine contraceptive device: a case report.
    Martin BR; Orr JW; Austin JM
    Am J Obstet Gynecol; 1983 Oct; 147(3):343-4. PubMed ID: 6684883
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Norplant subdermal contraceptive system: experience in Taiwan.
    Tseng LH; Lee TY; Yang YS; Ko TM; Chuang SM
    Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Norplant contraceptive implants: rods versus capsules.
    Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
    Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
    [TBL] [Abstract][Full Text] [Related]  

  • 73. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.
    Rotmensch S; Cole LA
    Lancet; 2000 Feb; 355(9205):712-5. PubMed ID: 10703803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Irregular heavy periods in adolescence: think of beta-hCG estimation.
    Ghosh T; Bickerton NJ
    J Obstet Gynaecol; 2004 Oct; 24(7):833-4. PubMed ID: 15763811
    [No Abstract]   [Full Text] [Related]  

  • 75. [Unusual antenatal gestational choriocarcinoma].
    Tardif C; Nowak C; Sagan C; Frenel JS; Philippe HJ
    Gynecol Obstet Fertil; 2014 Oct; 42(10):725-8. PubMed ID: 25242439
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute abdomen as initial presentation of gestational choriocarcinoma.
    Liberis V; Bouchlariotou S; Ammari A; Psillaki A; Ntatidou M; Sivridis E; Dislian V; Koutlaki N
    Arch Gynecol Obstet; 2009 Nov; 280(5):859-62. PubMed ID: 19288267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Choriocarcinoma as a cause of thyrotoxicosis.
    Morley JE; Jacobson RJ; Melamed J; Hershman JM
    Am J Med; 1976 Jun; 60(7):1036-40. PubMed ID: 945690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
    Creinin MD
    Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.